Business Daily from THE HINDU group of publications
Saturday, Sep 02, 2006


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - People
Industry & Economy - Venture Capital
Matrix promoter may turn angel investor

C.R. Sukumar

Evaluating various options of investment: N. Prasad

Hyderabad , Sept. 1

Richer by Rs 570 crore, Matrix Laboratories Ltd's chief promoter, the 45-year-old Mr N. Prasad, is actively weighing options on turning into an angel investor.

Having divested 12 per cent of his stake in Matrix to US pharma generics major Mylan Laboratories Inc, for roughly Rs 570 crore, Mr Prasad has already given indications of his route to angel investor.

His investments at present are in the entertainment, healthcare and infrastructure segments. Mr Prasad is currently evaluating various industrial sectors for making fresh investments through the recent proceeds.

Maa TV, Care Hospital, Asian Institute of Gastro-enterology and Indu Projects are a few entities in which he had acquired equity stake for a cumulative investment of around Rs 100 crore.

However, Mr Prasad has not yet crystallised his plans whether to continue investments in various key industrial segments through private equity fund route or to invest towards becoming a full-fledged entrepreneur once again developing companies right from scratch.

"The first innings is over. I am highly satisfied with the results and my contribution to the Indian industry and economy in terms of wealth creation. I could successfully create a wealth of over $1 billion (Rs 4,600 crore). My second innings as an entrepreneur will begin soon," Mr Prasad told Business Line from the US.

According to him, he is free to invest anywhere other than pharma industry in view of his commitment to Matrix Labs.

"The idea behind retaining an equity stake of five per cent in Matrix and investing $25 million in Mylan and joining their management team heading the global business strategies is to ensure confidence levels of the Matrix shareholders, employees and also to the new partner - Mylan."

Mr Prasad says he would be very active in the pharma space for some more time. In fact, he would now be entering the higher orbit of pharma space with his new role as head of Mylan's global strategies in the office of the CEO.

Responding to a query on his investment plans, he said, "I have several industrial segments in mind. However, nothing has been firmed up so far.

Whether to continue investing in various entities as an angel investor with the recent proceeds or think of becoming entrepreneur once again is not yet fully crystallised.

It may take some more time to arrive at a decision."

Related Stories:
Mylan to buy Matrix for $736 m
Nimmagadda Prasad: `Fastest wealth creator' in Indian pharma space

More Stories on : People | Venture Capital | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Prithvi targets 4-5 buys of $10-20 m each


GAIL pays total dividend of Rs 484.94 cr
Punj Lloyd bags IOC order
German co chooses ICIL as outsourcing partner
Award for ONGC Director HR
TNT Express buys Speedage
BV Biologicals sets up biocontainment plant
Paradip-Haldia pipeline delayed
Anand Auto plans Rs 500-cr expansion
Expert's tips on doing business in China
Strides to acquire Singapore generics co
Deora urges oil PSU officers to drop strike plan
HAL, EADS sign pact
Arvind Brands forms JV with VF Corporation
Petronet, Adani to set up cargo port at Dahej
IOC to rope in foreign partners for exploration under NELP-VI
SAIL open to joint ventures abroad
Ministry yet to consider RIL's request on export of surplus LPG
Ford study for indigenisation of diesel engines
DCW plans Rs 525-cr capex
Michelin plans to enter two-wheeler tyre market
Scorpio posts record sales
Maruti sales up 16 % in Aug
Bajaj bike sales up 21 pc in Aug
Hero Honda sales down
TVS Motor sales rise 39 pc
Ford India sales up 88 pc
Matrix promoter may turn angel investor
Ratan Tata to be Chairman of Energy Brands Inc


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line